DeBio Network, a medical blockchain startup that was awarded the Healthtech Innovation of The Year Award from CNBC Indonesia, received funding of USD 2.35 million.
Pandu Sastrowardoyo, CEO of DeBio Network, mentioned the importance of innovation in healthcare. Moreover, the need for this service is urgent with the pandemic that is still happening today.
"Health technology is a crucial sector for Indonesia. With a population of 280 million, the potential is huge, and it will soon become our collective concern," said Pandu, in a statement received by us.
DeBio Network is the first anonymous medical and biomedical platform for users who wish to require medical tests and samples from home. DeBio is built on Substrate, the blockchain framework behind the Polkadot & Kusama ecosystem.
With the blockchain solution in use, the confidentiality and anonymity of user data is guaranteed for those who need tests and samples from home.
"The use of web3 technology even allows users to monetize their health data with guaranteed identity privacy that is maintained," explained Pandu.
Blockchain Potential for Healthcare Innovation
Dr Mariya Mubarika, Expert Board of the Indonesian Integrated Digital Doctors Association and chairman of the PB IDI Legislation Advocacy Division, revealed that blockchain innovation is indeed needed to develop the medical world.
"In addition to minimizing incidents of data misuse, blockchain is also recognized as an authentication provider to verify user access to health-related data services using only one identity. Besides that, it can also contribute to personalized healthcare," said Dr Mariya.
He further revealed that the application of blockchain allows doctors to monitor patients more efficiently.
"Blockchain helps doctors track patient data more easily by using timestamps that are recorded for each transaction, so patients can be monitored more closely and can be taken quickly when critical and emergency problems occur," he added.
